54 reports

  • PELAIA G, ET AL. (2012). THE POTENTIAL OF BIOLOGICS FOR THE TREATMENT OF ASTHMA. NATURE DRUG DISCOVERY; 11: 958-972
  • MACNEE W (2006). PATHOLOGY, PATHOGENESIS, AND PATHOPHYSIOLOGY. BRITISH MEDICAL JOURNAL; 332: 1202-1204

MUCOSAL IMMUNOLOGY; ##(##): ##-## WITHERS AL (2012).

  • Cystic Fibrosis
  • Vitamin
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC

Tier ##: revenue > USD ## billion; tier ##: USD ## million ≤ revenue ≤ USD ## billion; tier ##: revenue < USD ## million.

  • Vitamin
  • Amway Corporation
  • ConAgra Foods, Inc.
  • General Mills, Inc.
  • The Kraft Heinz Company
  • 8. Cystic Fibrosis Company Profiles, Approved & Pipeline Product Analysis
  • 8.2 NOVARTIS

It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases.

  • Cystic Fibrosis
  • Vitamin
  • World
  • Market Size
  • AbbVie Inc.

It deals in a variety of therapies of anti-infectives, inflammation and immunology, internal medicine, and oncology.

  • Vitamin
  • Amway Corporation
  • Bayer AG
  • Pfizer Inc.
  • Procter & Gamble Company

Figure ##.

  • Vitamin
  • United States
  • Amway Corporation
  • Chobani LLC
  • Herbalife Ltd.

IT PROVIDES PHARMACEUTICALS IN CANCER, NEUROSCIENCE, INFECTION, IMMUNOLOGY, OPHTHALMOLOGY, CARDIOVASCULAR AND METABOLISM, IMMUNOLOGY, HEMATOLOGY, HEMOPHILIA AND RESPIRATORY DISEASE AREAS.

  • Vitamin
  • Brazil
  • Russia
  • Forecast
  • Market Segment

According to the Colombian Association of Allergy and Immunology there are between four and five million Colombians suffering from food allergies.

  • Vitamin
  • Colombia
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Tecnoquímicas SA

According to the Sociedade Portuguesa de Alergologia e Imunologia Clínica (Portuguese Society of Allergology and Clinical Immunology - SPAIC), more and more people are suffering from respiratory allergies, especially rhinitis.

  • Vitamin
  • Portugal
  • Demand
  • GlaxoSmithKline plc
  • Unipessoal, Lda

IT PROVIDES PHARMACEUTICALS IN CANCER, NEUROSCIENCE, INFECTION, IMMUNOLOGY, OPHTHALMOLOGY, CARDIOVASCULAR AND METABOLISM, IMMUNOLOGY, HEMATOLOGY, HEMOPHILIA AND RESPIRATORY DISEASE AREAS.

  • Vitamin
  • East Asia
  • Forecast
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche Ltd.

You can easily book an appointment with one online.

  • Cystic Fibrosis
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG

EDIT COMPLETED HER PHD IN CANCER IMMUNOLOGY/ IMMUNOTHERAPY AT ST.

  • Cystic Fibrosis
  • Vitamin
  • Novartis AG
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated

Some players compete by increasing their range of products and employing direct sales agents, who deal with retailers one-on-one.

  • OTC
  • Vitamin
  • Cameroon
  • Demand
  • Sanofi S.A.

With three major research centres located in Germany, Austria and the US, the company' s main areas of development are focused on immunology and diseases of the respiratory, cardio-metabolic and central nervous systems as well as non-clinical drug development.

  • Vitamin
  • Brazil
  • Demand
  • Farmacêutica Ltda
  • Sanofi S.A.

The company will however focus new product development on Rx medicines, with a focus on rare diseases, diabetes, cardiovascular diseases and immunology.

  • OTC
  • Vitamin
  • Italy
  • Demand
  • Angelini Group

The segment recorded ##% sales growth in oncology therapeutic area and ##% in immunology.

  • Vitamin
  • Europe
  • Market Size
  • DiaSorin S.p.A.
  • Roche Group

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Cystic Fibrosis
  • Therapy
  • United States
  • World
  • Product Initiative

The current products for IPF have generated global revenues in excess of $## billion in 2016.

  • Cystic Fibrosis
  • Healthcare
  • Pharmaceutical
  • Australia
  • Pharmaxis Ltd
  • PRODUCTS UNDER DEVELOPMENT BY UNIVERSITIES/INSTITUTES, H1 2018

SYNTHETIC PEPTIDE TO TARGET TLR-## FOR ONCOLOGY, IMMUNOLOGY AND INFECTIOUS DISEASE - DRUG PROFILE Synthetic Peptide to target TLR-## for Oncology, Immunology and Infectious Disease Synthetic peptide is under investigation for the treatment of gram-negative bacterial infections includ

  • Anti-Infective
  • Cystic Fibrosis
  • Vitamin
  • United States
  • Product Initiative

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Cystic Fibrosis
  • United States
  • World
  • Product Initiative
  • Proteo Biotech AG

It develops and produces medicines and vaccines for a wide range of medical disciplines including immunology, oncology, cardiology and neurology.

  • Vitamin
  • World
  • Market Size
  • Amway Corporation
  • Pfizer Inc.

The increased loss in the quarter and twelve-month period ended December ##, 2016, compared to the prior year, was the result of increased clinical trial costs related to two Phase ## studies and one Phase ## study conducted during 2016, compared with only a single Phase ##b study and

  • Cystic Fibrosis
  • United States
  • Company
  • M&A
  • Nivalis Therapeutics, Inc.

It caters services to cardiovascular & metabolism, immunology, infectious diseases, vaccines, neuroscience, Oncology and other therapeutic areas.

  • Cystic Fibrosis
  • United States
  • Company
  • Company Operations
  • Vertex Pharmaceuticals Incorporated

The company reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Cystic Fibrosis
  • United States
  • Company Financials
  • M&A
  • RP Management LLC
  • MERCK & CO., INC.: COMPANY SNAPSHOT (2018)

The company offers products for major therapeutic applications, such as cardiovascular disease, respiratory disease, oncology, neuroscience, infectious disease, immunology, and women' s health.

  • Vitamin
  • North America
  • United States
  • Market Size
  • GlaxoSmithKline plc

THE DIS SEGMENT ALSO OFFERS TESTS IN VARIOUS FIELDS, INCLUDING ENDOCRINOLOGY, IMMUNOLOGY, INFECTIOUS DISEASES, NEUROLOGY, ONCOLOGY, AND CARDIOLOGY.

  • Cystic Fibrosis
  • Molecular Diagnostics
  • North America
  • United States
  • Invitae Corporation

The segment recorded ##% sales growth in Pharmaceuticals PHARMACEUTICALS ##% Source: Technavio, 2015 the oncology therapeutic area and ##% in immunology.

  • Vitamin
  • United States
  • Market Size
  • DiaSorin S.p.A.
  • Roche Group

Partner ## Partner ## Deal status PTC Therapeutics, Inc.

  • Cystic Fibrosis
  • Healthcare
  • Therapy
  • Vitamin
  • PTC Therapeutics, Inc.
  • CYSTIC FIBROSIS FOUNDATION THERAPEUTICS ENTERS INTO RESEARCH AGREEMENT WITH SHIRE

It provides products across various therapeutic areas including hematology, neuroscience, immunology, genetic disease, ophthalmic, gastrointestinal, endocrine, hereditary angioedema, cancer and other diseases.

  • Cystic Fibrosis
  • Pharmaceutical
  • Therapy
  • United States
  • Proteostasis Therapeutics, Inc.

SR One Ltd.

  • Cystic Fibrosis
  • Pharmaceutical
  • Therapy
  • United States
  • Company

Partner ## Partner ## Deal status PTC Therapeutics, Inc.

  • Cystic Fibrosis
  • Healthcare
  • Therapy
  • Vitamin
  • PTC Therapeutics, Inc.